We compared performance levels of four clinical laboratory groups defined by federal regulatory characteristics, to assess the appropriateness of selected regulations: laboratones in JCAH-accredited hospitals; non-doctoral-directed independent laboratories; state-regulated but federally exempt group-practice laboratories; and unregulated laboratories in physicians' offices (POLs). Federal regulations evaiuated were those dealing with the doctoral directorship requirement and exemption of POLs from regulation. Quantitative analytes were compared by using linear regression on log-normal transformations of mean absolute..z scores of proficiency test results. The scope of services offered by laboratories was statistically related to performance in quantitative analytes. Confounding effects of scope-of-service levels were statistically controlled. Proportions of errors in qualitative analytes were compared. No pattem of statistically discernible differences in performance was found between hospital laboratories and non-doctoral-directed laboratories.
This article presents the findings of an investigation commissioned by the U.S. Centers for Disease Control (CDC) (1) to expand earlier research into. the presumed relationship between laboratory "quality" (i.e., performance) and regulatory standards (2). Both research projects investigated (a) the theoretical impact on laboratory performance offederal requirements that directors offederally licensed or certified laboratories must hold earned doctorates, and (b) the impact on laboratory performance ofregulatory systems in general. Although the two research projects were not originally conceived as two parts of a single investigation, the second project was designed to augment the first. Consequently they fit together as if they had been planned as Parts I and H of an overall research design. In order to conveniently distinguish between the two research projects in this article, the original research is referred to as "Part F' and this project is referred to as "Part IF'.
Using 1983 proficiency test data from the American Association of Bioanalysts (AAB) and American Society of Internal Medicine (ASIM) proficiency-testing services (3),
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Received January 28, 1987; accepted February 13, 1987. Comparisons were made on results for nine chemistry analytes and two indices of chemistry performance, five hematology analytes and two indices of hematology performance, syphilis serology, rubella, diagnostic inununology, parasitology, bacteriology, immunohematology, and ui-inalysis. For data reported in continuous form, the Izi score was the test statistic. The Kruskal-Wallis and Wilcoxon rank sum tests were the statistical procedures used in making the comparisons. For qualitative data, comparisons were made on the proportions of errors reported by using Cochran's method for calculating the variance of clustered data (4) . No statistically discernible differences in performance were found among the five full-service independent laboratory study groups. All five study groups were found to belong to one homogeneous group ofregulated independent full-service laboratories.
These findings indicate that a director's doctoral degree is not a necessary condition to assure laboratory performance as measured by proficiency testing.
Part I also compared the performance ofthe non-doctoraldirected laboratory group with a group of laboratories in physicians' offices (POLs) that were neither licensed by the State ofCalifornia nor certified by Medicare. The unregulated POLS were operationally defined as "limited-service" laboratories, in contrast to the full-service non-doctoraldirected independent laboratories. The same statistical testung methodology was applied to this comparison as described above; however, because the POLs were limitedservice laboratories, there were only five chemistry analytes and five hematology analytes in the analysis, along with indices ofchemistry and hematology. In this set of comparisons, the non-doctoral-directed laboratories were statistically superior in performance in all comparisons except for one analyte.
A key dimension of the analysis was the impact of mandatory regulation itselfon laboratory performance. The two study groups consisted of one regulated group (the nondoctoral independent laboratories) and one unregulated group (the POLs). The regulated laboratories were under both Medicare regulations and even more stringent Califorma standards.
The data seemed to indicate that the key variable in assuring better performance by the non-doctoraldirected laboratories was the fact that they were regulated under two comprehensive regulatory systems. An important feature ofthe Part I investigation was that hospital laboratories were not included in the analysis. Hospital laboratories are in almost all cases officially directed by clinical pathologists and are often considered to represent the highest levels of quality in the clinical laboratory profession. Further analysis would be needed to determine if non-doctoral-directed laboratories in the independent setting perform as well as pathologist-directed hospital laboratories.
A second ambiguity of the original analysis is that a potential bias against the POLs was deliberately introduced into the investigation.
There is a widespread belief among members of the laboratory profession that laboratories with a broad range (scope) of services perform with greater accuracy and precision than do laboratories with limited ranges of service. Comparing limited-service POLs with full-service non-doctoral-directed independent laboratories thus introduced a potential confounding variable-scope of services. POLs were selected into the study at limited scopeof-services levels to provide a stringent test ofthe hypothesis that the M.D. degree(s) of the physician(s) in charge of the office laboratory is a sufficient condition to assure acceptable levels of performance.
If the M.D. degree does confer the presumed quality-assurance effect, then the effect should be visible at any scope-of-service levels.
However, because scope of services may influence performance independently of the doctoral degree of the dimetor, the consistent pattern of lower levels ofperformance by the POLs that was found in Part I might be attributed either to their exemption from regulation or to their lower scope-ofservices levels. For regulatory purposes, it would be valuable to know ifthe observed differences in performance were a result of exemption from regulation for the POLs,lower scope-of-services levels in the POLs, or both. CDC commissioned Part II to provide additional empirical evidence that could help in assessing both (a) the role of doctoral directorship in assuring clinical laboratory performance when hoepital laboratories are added to the analysis, and (b) the effects of government regulation on laboratory performance when the effects of scope of services on laboratory quality are held constant.
Methods
As in Part I, this investigation was designed to comprise two distinct but related analyses. The first was to compare doctoral-directed (hospital) laboratories and non-doctoraldirected (independent) laboratories, to assess the validity of the federal regulations requiring an earned doctorate for licensure or certification of clinical laboratories (and, mdirectly, requirements of voluntary acerediting agencies and state regulatory systems for doctoral directors). The second was to compare regulated and unregulated laboratories while removing the confounding variable ofscope of services to assess the validity of the policy of exempting POLs from regulation.
Laboratory Characteristics-the Independent Variables
The assessments included in Part II were designed to measure the presumed effects of certain key characteristics of clinical laboratories on laboratory performance. Laboratories are grouped in this analysis into comparison groups according to these particular key characteristics, which are treated as the independent variables in the investigation. Unlicensed laboratories in physicians' offices (U-POLs). These laboratories are exempt from federal (Medicare) regulation and they are also exempt under state law from licensure-and therefore from state regulation.
To secure exemption from state licensure they must meet the following criteria: (a) They must be exclusively owned and operated by a solo-practice physician or by the members ofa small group practice. (b) In the case ofgroup-practice laboratories, all members of that group practice must share in the supervisory responsibilities of the laboratory to the extent that each uses the laboratory. (c) They may not accept any patients or specimens for analysis from any physician outside ofthe practice. They key characteristics ofthis study group are (a) doctoral directorship, (b) physician's office setting, and (c) exemption from state and federal regulation (5) .
Medicare-exempt laboratories. These are laboratories in physicians' or group-practice offices that are licensed by the State of California and that therefore come under state regulatory standards. These laboratories may have voluntarily sought licensure in order to participate in an external quality-assurance program, or they may have been required by state regulations to obtain licenses (5). They have applied for and received exemption from compliance with federal (Medicare) regulatory standards under the physicians' office exemption criteria (6). By and large, these laboratories are in large group-practice offices and may be thought of as a type of "licensed physicians' office laboratory," even though they do not conform in all respects to State of California criteria for defining U-POLs. The key characteristics of this group are (a) state licensure (regulated status), (b) physicians' office setting, and (c) doctoral directorship.
This classification scheme for study groups produced three two-way comparisons in the analysis:
(1) Non-doctoral and hospital laboratories. This comparison centers on the doctoral directorship characteristic, which differs for the two groups. There is also an indirect focus on the effects of JCAH accreditation, because all hospital laboratories in the study are JCAH accredited.
(2) Non-doctoral directed laboratories and U-POLs. This comparison involves two foci of interest. The first is on the in 1983 to the full-service proficiency testing package. We identified 70 hospital laboratories that met the full-service criteria.
License-renewal applications for all 70 hospital laboratories were then reviewed. Six hospital laboratories were removed from the study group because they had "mixed" directorship-they had co-directors who were both physicians and non-doctoral bioanalysts. These laboratories were removed to assure a homogeneous doctoral-directed hospital laboratory group for comparison with the non-doctoral group. Laboratories in nine non-JCAH-accredited hospitals were also removed from the study to provide another aspect of homogeneity-all hospital laboratories in this analysis are in JCAH-accredited facilities. This allows for a partial assessment of the quality-assurance effect of JCAII standards as related to laboratory performance (8).
Unlicensed laboratories in physicians'
offices. A set of inclusionlexclusion criteria was developed to guide selection ofU-POLs for the study. The first criterion was to select fullservice U-POLs for the study. Unlicensed laboratories in physicians' offices are identified by their state proficiencytesting identification numbers. Using computer printouts from the AAB and ASIM proficiency-testing services, we identified laboratories with both U-POL identification codes and full-service subscription codes for possible inclusion in the study (9).
The second step in selecting the U-POL comparison group was to eliminate from the analysis the 16 full-service UPOLs identified in the original study that reported identical or nearly identical proficiency-test scores and identical scope of services. They were excluded on the assumption that these laboratories coordinated their responses. Coordinated reporting creates a lack of independence in interlaboratory comparisons that invalidates inferential statistical analysis. (See Appendix A for a discussion of how these laboratories were identified.) We selected 100 full-service U-POLs for the study. 
Statistical Testing Methods
As in Part I, the mean absolute z-score (Izi) was the test statistic used for comparisons involving continuous data, because it is a measure oflaboratory performance that is not affected by the choice of analytical methods used in those laboratories being studied. Also as in Pat I, the test statistic for inferential statistical analyses involving qualitative data is the proportion of errors made by each laboratory in measuring the analyte, or in the specialty being studied. These methods are described in detail in the report of Part I (2). However, in this analysis the mean Izi was converted to its natural logarithm to provide a parametric distribution for multi-variate analysis needed to remove the confounding effects of the scope of service on laboratory performance (see below).
Analytes/Indices Included in the Analysis
Continuous data format. As in Part I, nine chemistry analytes (bilirubin, calcium, cholesterol, creatunune, glucose, potassium, sodium, urea nitrogen, and uric acid) and five hematology analytes (erythrocytes, hematocrit, hemoglobin, leukocytes, and prothrombin) were included in the analysis as performance measures of continuous data. In addition we used a chemistry index combining scores for all nine chemistry analytes as a summary measure of chemistry performance as well as a hematology index combining scores from the five hematology analytes. Syphilis serology was treated as a continuous outcome variable.
Dichotomous data format-chemistry and hematology indices. The proportion of chemistry and hematology errors made by the various licensed-laboratory study groups was used as a second summary measure of laboratory performance in these specialties. The use ofthe proportion of errors as a test statistic is described in the report of Part I (2).
Dic/zotonwus data format-qualitative procedures. In Part I, I evaluated the following qualitative analytes/procedures: bacteriology, parasitology, diagnostic immunology, blood grouping/typing, irregular antibodies, rubella, and urmnalysis. In Part II, blood grouping and typing, irregular antibodies, and rubella were eliminated because there were so few errors in the sample that no meaningful comparison was possible. The test statistic used for comparisons of bacteriology, parasitology, diagnostic immunology, and urinalysis was the proportion of errors identified.
Additional dichotomous comparison-electrolytes. While we were hand-coding data for this report, it appeared that no -
there might be significantly different proportions of errors among the study groups in electrolyte reporting. Because accuracy ofelectrolyte reporting is particularly important in clinical diagnosis, the three electrolytes in this study (calciurn, potassium, and sodium) were combined into an electrolyte index. The proportions oferrors for electrolytes for each study group were compared.
Complications in the Scope-of-Services Variable
All laboratories selected for this study subscribed to "fullservice" proficiency-testing programs. This selection criterion was used to ensure that all laboratories were comparable with respect to the scope of services they provided, thus removing scope of services from the analysis as a potential confounding co-variable. An unexpected discovery during hand-coding ofdata for this analysis was that the nominally full-service U-POLs did not in fact report the same breadth of services as the non-doctoral laboratories.
The U-POLs both skipped more quarters of reporting and reported fewer analytes per quarter than did the licensed groups.
This unexpected finding required us to develop a measure of scope of services reported, and statistical testing to determine (a) ifthere are statistically significant differences between study groups in the scope of services reported and (b) ifthere is a statistically significant relationship between the levels of scope of services offered and the performance of participating laboratories (10). A scope-of-services measure was computed by calculating the mean number of reports (for all specimens) per laboratory per quarter for all analytes included in the study for the year 1983. The hospital and non-doctoral-directed laboratories were similar in this measure, with hospital laboratories having a mean score of 51.95 reports per quarter and non-doctoral laboratories having a mean score of 52.51 reports per quarter. The nominally full-service U-POLs rEnCrNI(ThE produced a mean score of 30.60 reports and the nominally full-service Medicare-exempt laboratories produced a mean score of 37.05 reports per quarter.
These data are presented graphically in Chart 1. A frequency distribution for all laboratories in the study was prepared that identified which laboratories fell into the highest through lowest quintiles on the scope-of-services measure. The quintile cut-points for the raw data for all reports for the year on the scope-of-services measure are: These cut-points mean that 20% of all laboratories fell into each of the specified ranges. That is, 20% of all laboratories were in the 0-71 range, 20% in the 72-113 range, and so on. If all study groups were reporting comparable scope-of-services levels, each group would have about 20% of its members within each quintile. This expectation was not met in the actual distribution.
Chart 1 shows the quintiles (labeled 1-5) and study group type on the horizontal axis. The vertical axis, when read in conjunction with the horizontal axis, shows the percentage of laboratories within each study group that fell into each scope-of-services quintile as defined by the total distribution of all study groups. For example, over 57% of the nondoctoral laboratories were in the highest 20% (quintile 5) of scope-of-services scores, while approximately 37% of the UPOLs (identified in Chart 1 as "unlicensed") fell in the lowest 20% (quintile 1) ofthe overall scope-of-services range.
Another way of looking at this analysis is that approximately 57% of the non-doctoral laboratories scored in the upper 20% of the scope-of-services range, while only 31% of
Scope of services by each study group: percentagesof analytes reported, by quinthes Seetext fordescriptionof asciiquintile the hospital laboratories scored in this range. The four comparison-group categories fit roughly into two subsets, with the non-doctoral and hospital laboratories showing the bulik of their reporting in the upper two quintiles while the bulk of the scores for both categories of physicians' office laboratories (Medicare-exempt and U-POLs) was in the lower three quintiles.
This chart indicates that the non-doctoral group has the most complete overall scope-of-services reporting pattern, followed by hospital laboratories, Medicare-exempt laboratories, and, lastly, by the U-POLs with the most incomplete pattern of reporting.
Linkage of Scope of Services to Performance
Once clear differences in scope of services among the study groups were identifIed, it was necessary to determine (a) ifthe differences in scope between the groups are statistically significant, and (b) ifwithin the study groups there are statistically significant relationships between scope of services and laboratory performance.
Differences between Study Groups in Scope of Services
We made three comparisons using the Wilcoxon rank sum test to determine if the scope-of-services measures for pairs of study groups were similar or dissimilar: (a) hospital and non-doctoral-directed laboratories; (b) non-doctoral-directed and U-POLs; and (c) U-POLs and Medicare-exempt laboratories. All three comparisons were statistically significant at the 0.05 level of significance.
Relationship between Scope of Services and Quality within Study Groups
A Spearman rank order correlation matrix was prepared, which identified the correlation coefficients and probability values associated with those coefficients for the relationship between scope of services and mean Izi scores for each continuous data analyte/prOCedUre in the analysis by study group. In most cases the correlation coefficients were positive, indicating that as the scope of service increases the accuracy of work within a study group also increases (and conversely, as scope of services decreases, the accuracy of work in the group decreases).
Of 72 comparisons, in 13 there was a statistically significant positive correlation between scope of services and performance at the 0.05 level of confidence. Most (nine) of these statistically significant relationships are within the U-POL group. In fact, this positive relationship was found in half of the analytes for the U-POL group. This set of relationships called for the development of multivariate approaches to control for the effect of scope of services on accuracy when assessing possible differences in performance among study-group types.
Controlling for the Effects of Scope of Services on Performance
No distribution-free (nonparametric) approach was found that would allow for a multivariate analysis to control for an intervening variable. The method selected to control for the effect of scope as an intervening covariable was to convert distributions of mean Izi scores to approximately symmetrical distributions with similar variances by computing the natural logarithm ofthe mean IzIscores. Plots ofthe natural logs of the mean IzI scores demonstrated a symmetrical distribution amenable to parametric inferential testing procedures.
The method for parametric inferential statistical testing we selected to compare study groups with the effect of scope of services identified as a covariable was linear regression with one independent variable, one dependent variable, and an interaction term (11, 12) . This method entailed a twostage analysis. The first stage involved a linear regression to determine if, for any psi-wise comparison (e.g., hospital vs non-doctoral-directed laboratories; non-doctoral directed laboratories vs U-POLs; and Medicare-exempt vs U-POLs), there was interaction present between the scope-of-services variable and performance. If interaction was found at the P 0.05 level of confidence, no further statistical analysis of the relationship between study-group type (the independent variable) and performance (the independent variable) was possible. In such cases, the results are given graphically in plots showing the regression lines for each pair of study groups as they intersect. There were only seven such cases out of 51 comparisons.
In addition, borderline interaction comparisons ('PP"value >0.05, <0.10) are also presented.
The second stage of the analysis was triggered if there was no statistically significant interaction at the 0.05 level of confidence. A second regression run was carried out to assess the strength oftwo relationships:
(a) the relationship between study-group type and performance and (b) the relationship between scope of services and performance. This run produced probability values for both components (study group and performance, and scope of services and performance).
Patterns of Results
There were four patterns of results in the two-step linear regression analysis:
(a) Interaction present. In this case there is no possibility of a direct comparison of laboratory type and performance, because the effects of scope of services on quality confound the primary analyses (the two-way comparisons between laboratory groupings determined by their key characteristics).
(b)No interaction, no statistically significant relationship between laboratory characteristics and performance, and no statistically significant relationship between scope of services and performance.
(c) No interaction, no statistically significant relationship between laboratory type and performance, and a statistically significant parallel relationship for both laboratory groups between scope of services and performance.
(d) No interaction, with a statistically significant relationship between laboratory type and performance, and a statistically significant relationship between scope ofservices and performance. These possibilities are represented schematically in Exhibit 1 as follows: Figure 1 shows crossing regression lines, indicating that for one study group there is a positive correlation between scope and performance while for the second this correlation is negative. Interaction also occurs when one group shows a horizontal regression line while the other crosses it. (Interaction could also occur when both study groups produce positive but differing slopes.) Figure 2 shows no statistically significant effects in any dimension. There is no interaction, as shown by parallel regression lines; there is no difference between the two study groups in performance, as shown by regression lines close together; and there is no relationship between scope and performance, as shown by horizontal regression lines. no performance difference (regression lines close together), but a statistically significant relationship between scope and performance for both study groups, as shown by regression lines going down the figure at an angle from left to right (because the vertical or performance axis has the highest level of performance at the lowest point on the scale). Figure 4 shows no interaction (parallel regression lines) but simultaneously a difference in performance between the two study groups (regression lines far apart) and a positive relationship between scope and performance (regression lines at an angle from upper left to lower right).
As in the original study, findings in this section are presented in tabular form. The graphic presentations of results in this report that follow the tabular data are in the form of the schematic models above.
Results
The CDC contract commissioning this study required that the methodology of Part I be used in this follow-up investigation. However, once it was determined that the laboratories selected for inclusion in this analysis were not homegeneous with respect to scope of services, even though they subscribed to the full-service proficiency testing package, the original methodology was no longer appropriate, at least for results reported as continuous data that could be traitsformed for use in a multivariate analysis to remove the confounding effects of differing scope-of-services levels. In order to meet contractual requirements, two separate analysea of continuous data analytes were run, one with the original methodology (Kruskal-Walhis and Wicoxon rank sum tests using mean al scores) and one with the multivariate methodology described here.
The results ofthe analysis using the original methodology are summarized but not presented in detail here. In the comparison without adjustment for scope-of-services effects, there were no statistically discernible differences in performance between the hospital and non-doctoral-directed laboratories in any analyte or index. In 20 of22 comparisons between the non-doctoral-directed regulated independent laboratories and U-POLs, the non-doctoral-directed laborstories demonstrated statistically higher levels of performance, and in one of the remaining comparisons the nondoctoral laboratory group was only 0.0022 away from statistically significant superiority as well. When state-regulated Medicare-exempt laboratories were compared with unregulated POLs, the regulated group demonstrated a statistically significantly higher level of performance in eight of 17 (47%) measures involving continuous data. The unregulated POLs were statistically superior in only one comparison, and in one comparison the two groups were comparable. When more-stable measures oflaboratory performance were achieved through aggregation of data into indices, the regulated laboratories demonstrated statistically discernibly more accurate performance than did the unregulated laboratories in chemistry and hematology. Table 2 gives results of the linear regression runs for analytes reported in the continuous data formats. The first column of Table 2 shows the analytes and indices used for each psi-wise comparison.
A. Part II Results-Continuous Data Format
The second column gives the probability values indicating the presence or lack of interaction in the comparison. The third column, labeled "quality," shows the probability that there is or is not a difference in accuracy between the two study groups in the case where there is no statistically significant interaction.
If there is statistically significant interaction present, an "NA" (for "not applicable") takes the place of the probability value in this column. The "NA" means that the two-stage process was halted after the first stage because it is not possible to test for the other hypothesized relationships when interaction is present. The "NA" indicator is placed in the fourth and filth columns also as an additional reminder that the analysis shifts from probability values to the regression line plots when there is statistically significant interaction prosent.
The fourth column, labeled "scope," gives the probability value that there is a statistically significant similar relationship between scope of services and performance for the two study groups being compared when statistically significant interaction is not present. Statistically significant relationships in columns 2-4 are highlighted by use of underscoring.
The fifth column, labeled "R2," gives the squared multiple correlation coefficient. This is a measure ofhow much of the variance in the data is explained by the variables in the linear-regression equation.
A high R2 (close to 1.0) indicates that the linear-regression model closely fits the data. In such a case the model is said to "explain" the data. However, a low R2 value indicates that there is a large residual amount of unexplained variance in the model-that the variables chosen for the model account for only a small portion of the observed variation in the data.
It is possible simultaneously to have statistically significant relationships among variables included in the analysis and low R2 values. In such cases it may be said that the model is able to detect statistically significant relationships between the variables included in the analysis in spite of the fact that those variables do not explain large portions of the variance found in the data. The more scatter in the data, the .55
performance, although one comparison approached statistical significance: for hematocrit the non-doctoral-directed laboratories showed lower mean Izi scores than the U-POL performance (P 0.07). Exhibit 3 shows the plot for the hematology index with interaction present. In this case the non-doctoral laboratories demonstrate the same performance level at all scopeof-services levels, while the U-POLs show a strong positive relationship between scope ofservices and performance. The work of U-POLs at lower scope levels is generally less accurate than that of the non-doctoral laboratories at the same scope-of-services levels.
The fact that the index ofnine chemistry analytes shows a statistically significant difference in quality may indicate that the index is a more useful variable than are individual analytes for a data set of this size, because it aggregates data into a unit that is large enough to provide adequate power to discriminate differences in performance between the pairs of study groups being compared. This same phenomenon occurs, for example, with the hematology index when the U-POLs and Medicare-exempt laboratories are compared by linear regression.
Interaction was also present in the hemoglobin comparison. Exhibit 4 presents a picture similar to that for the hematology index. At lower scope levels the U-POLs perform less accurately than the non-doctoral laboratories with the same scope of services.
Calcium produced borderline interaction (P = 0.06) (Exhibit 5). This comparison also fits the pattern of lower performance levels from the U-POLs at the lower scope levels.
Finally, there was borderline interaction (P <0.10) in urea nitrogen (Exhibit 6). In this case, even though scope and performance were inversely related for the non-doctoral-directed laboratories, the non-doctoral laboratories also demonstrated better performance at the lower scope levels. Performance appeared to be roughly equal at about the midpoint of the scope-of-services axis.
Our results for the linear regression reinforce those obtained in the Spearman rank-order correlation analysis. In both cases the U-POL group showed the greater number of statistically significant relationships between scope of services and performance.
It may be that licensed laboratories must be larger than unlicensed laboratories to be able to generate sufficient income to meet licensure standards and those standards may assure a more consistent performance.
Comparison three-Medicare-exempt laboratories and UPOLs. There was statistically discernibly better performance by the regulated Medicare-exempt laboratories than by unregulated POLS for calcium, potassium, glucose, sodium, hematocrit, and the hematology index.
Interaction or borderline interaction was present for four analytes. In all four (bilirubin, cholesterol, chemistry index, and hemoglobin) the Medicare-exempt laboratories had an inverse relationship between scope and performance while the U-POLs showed a positive relationship between scope and performance (Exhibits 7-10). There was higher performance for the Medicare-exempt laboratories than for the U-POLs at the lower scope ranges, with equality of performance reached near the mid-point of the scope range in three cases (bilirubin, cholesterol, and hemoglobin) and toward the end of the scope range in the chemistry index.
In this set of comparisons there are two predominant findings: (a) Licensed Medicare-exempt laboratories show a more consistent (but not complete) pattern of higher performance than do unlicensed physicians' office laboratories.
(b) Scope of services is an important variable in spite of the ambiguity presented by the two interaction and two borderline interaction cases. In six ofthe 14 cases where there was no interaction present there was a statistically significant positive relationship between scope and performance for both study groups. Where there was interaction present, the Medicare-exempt laboratories showed greater accuracy than did the U-POLs at the lower scope-of-services ranges.
Two additional notes are in order: First, the pattern of superior performance by the Medicare-exempt laboratories cannot be conclusively ascribed to licensure, because the groups are not identical in all other aspects. On the average, the Medicare-exempt laboratories are larger than the UPOLs. This may mean that they are better capitalized and thus able to purchase more sophisticated equipment and to hire a greater variety of more highly trained and (or) experienced personnel. Second, the Medicare-exempt group is small for the purposes of statistical comparison. Possibly, results might differ if the Medicare-exempt group were larger-the observed inverse relationships between scope and performance might even disappear with a larger study group.
B. Part II Results-Dichotomous Data Format
Comparison one: hospital and non-doctoral laboratories. We found no statistically discernible differences in performance between hospital and non-doctoral laboratories in the proportion of errors committed in hematology, parasitology, diagnostic immunology, or urinalysis. All confidence intervals overlapped for these analytes (13). Hospital laboratories produced statistically significantly lower proportions of errors in both the index of all chemistries and in the electrolyte index. Non-doctoraldirected laboratories produced statistically significantly lower proportions of errors in bacteriology. These results are presented in Tables 3 and  4 , which summarize findings for all three pairwise comparisons.
Comparison two-non-doctoral laboratories and U-POLs. No statistically significant difference was found between non-doctoral laboratories and U-POLs in the proportion of errors in diagnostic immunology. In the proportion of total errors in hematology, electrolytes, bacteriology, parasitology, and urinalysis, the non-doctoral laboratories demonstrated statistically significantly better performance than the U-POLs.
Comparison three-U-POLs and Medicare-exempt laboratories. No statistically significant difference was found in the proportion of errors in urinalysis between licensed Medicare-exempt laboratories and unlicensed U-POLs. In the proportion oftotal errors in hematology, bacteriology, parasitology, and electrolytes, Medicare-exempt laboratories produced statistically significantly higher performance 1ev-els than the U-POLs. U-POLs had a statistically significantly lower proportion of errors than did Medicare-exempt laboratories in diagnostic immunology. Visual plots of the data (shown in the original report to CDC) show that the Medicare-exempt laboratories have tighter distributions of mean IzI scores than do the U-POLs in all analytes and indices reporting in the continuous data format, indicating higher general precision. This finding is also visible in tabular data presented in the original report. In four of the qualitative comparisons there were no statistically discernible differences in performance between the two study groups. In two comparisons (the chemistry and electrolyte indices) the hospital labora- tories showed statistically better performance, and in one comparison (bacteriology) the non-doctoral-directed laboratories performed statistically better. Comparison 2. When regulated non-doctoral-directed independent laboratories were compared with unregulated physicians' office laboratories, there were no statistically significant differences in most comparisons. Interaction was 'The urinalysis data for non-doctoral-directedlaboratoriesdiffer in this reportfrom the original because of an apparent error in the way data were entered onto the originaldata tapes from the proficiency-testing service.It appears that urinalysis data for the secondquarter of 1983 were put on the tape instead of third-quarter data.Theunnalysisdatain this report are correct.
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tically discernibly superior to the unregulated POLs in five comparisons.
No statistically significant differences were found in the sixth comparison. Controlling for the effects of scope of services on laboratory performance removed much of the apparent difference in performance between the regulated non-doctoral-directed laboratories and POLS reported in Part I. However, a detectable pattern of superior performance by the regulated laboratories persisted, even after scope of services was controlled for.
Comparison 3. In eight of 17 comparisons of quantitative procedures or indices of quantitative procedures between regulated group-practice laboratories (Medicare-exempt) and unregulated physicians' office laboratories we found no statistically discernible differences in performance. In four comparisons, interaction or borderline interaction was present, which meant that the comparisons could not proceed. In six cases the regulated laboratories performed at statistically discernibly higher levels than the unregulated laboratories.
Graphic presentations of the data also showed a strong but not complete pattern of superior performance by the regulated physicians' office laboratory group over the unregulated group. The state-regulated laboratories in group practices demonstrated statistically discernibly higher levels of performance in four out ofseven comparisons involving dichotomous data (proportions of errors). In one, the relationship was reversed, with the unregulated laboratories demonstrating statistically discernibly higher performance, and in one comparison there was no statistically discernible difference between the two groups. Graphic presentation of the data verified the pattern of superior performance by the regulated laboratories when compared with unregulated laboratories.
Discussion

Research Design Limitations
The findings ofthis research project should be interpreted in the context of the following research-design limitations: Geographic focus. For the analysis I used performance data for clinical laboratory comparison groups in one state, California. Because California has one of the few comprehensive state programs regulating clinical laboratories, findings from this investigation may not be directly applicable to other states.
Proficiency-testing limitations. Proficiency-testing data were used as the outcome measure of laboratory performance ("quality"). Proficiency testing is an imperfect and incomplete measure oflaboratory performance; it is generally thought to measure the "best a laboratory can do" rather than routine performance.
Incomplete sampling. The study used proficiency-testing data from the AAB and ASIM proficiency-testing services, but it did not include data from the College of American Pathologists. CAP subscribers were not included because too few non-doctoral-directed laboratories in California subscribe to the CAP proficiency-testing program to provide an adequate sample size upon which to base inferential statistical comparisons of performance between doctoral-and nondoctoral-directed laboratories.
There is potential for bias in the selection of hospital laboratories for inclusion in the study. First, the hospital laboratories are self-selected into the AAB/ASIM proficiency testing system; none subscribe to the CAP's proficiency-testing program. Therefore, these hospitals may not be representative of all hospitals in the state. Second, there appears to be overrepresentation of smaller, rural hospitals in the sample.
Limited timE frame. Proficiency-testing data collected in 1983 were used for this analysis. One year may provide too small a data base to yield enough statistical power to discriminate levels of performance between laboratory study groups in all or some of the analytes included in the investigation.
Limited number ofoutcome measures. The analytes/procedures selected for use as dependent variables in this analysis are limited to those currently most commonly performed in clinical laboratories.
More unusual and more complex procedures not included in the study might offer a more suitable basis for discriminating differences in performance between hospital and non-doctoral-directed laboratories. For example, no statistically significant differences were found in comparisons of performance between hospital and nondoctoral-directed laboratories in any quantitative analyte or index of quantitative analytes. This finding does not necessarily mean that no such statistically discernible or operationally significant differences exist between these two groups, but only that this analysis, with its limitations, did not uncover any such differences.
Scope-of-services limitations. Laboratories in this study are limited to those subscribing to the "full-services" proficiency-testing packages of the AAB and ASIM proficiencytesting services. A broader analysis that included all levels of scope-of-services subscriptions might well have produced stronger evidence linking performance to scope-of-service levels in general and more statistical evidence specifically indicating that unlicensed laboratories at low scope of services perform less well than their licensed counterparts.
Definition oflaboratory practice. In both Parts I and II the assumption is made that the clinical laboratory profession is separate from the practice of medicine. Federal regulations, attorneys-general opinions, and court decisions that hold that the clinical laboraory profession is separate from the medical profession were cited in support of this assumption in the report to CDC. However, this assumption is challenged by many who feel that there are dimensions of laboratory quality (other than production of accurate, precisc, and timely analytical reports) that cannot be satisfactorily addressed if laboratories are not directed by persons who have medical training and experience that will ensure correct ordering and interpretation of test results (see Appendix B).
The two opposing views highlight the lack of agreement on the role of clinical laboratory directors: one sees the director's role as overall management; the other sees direction of clinical laboratories as inextricably embedded in the practice ofmedicine. There will be no agreement on the role of the director of clinical laboratories until these two opposing views have been resolved.
Research Design Strengths
It is important to keep in mind the research design limitations listed above, but it is also helpful to keep in mind the strengths of this research design:
. The definition of the independent variables (laboratory characteristics)
is related to federal and state regulatory requirements.
The operational definitions of laboratory study groups form the basis for empirical assessments of specified provisions in state and federal regulatory programs.
. Proficiency testing data are widely accepted by the clinical laboratory profession and federal and state regulatory agencies as a valid, if imperfect, measure of laboratory performance. Proficiency test data can discriminate differing levels ofperformance among laboratory groups, whether or not the widely held assumption that proficiency testing measures the best that laboratories can do is valid or partly valid.
. This investigation includes a substantial, iflimited, data base. All eligible full-service hospital, non-doctoral, UPOLs, and Medicare-exempt laboratories in California are included in the analysis. Within the 1983 data set there is no sampling error.
. Appropriate standard methods of inferential statistical testing were used to test the relationships under investigation. Those methods provide valid assessments of observed differences in performance between study groups. Other investigators may use this same methodology to attempt to repeat these findings, using data from other states or years.
. The findings ofthis analysis may be compared with those of Part I to assess the validity of each set of findings.
Conclusions
The objectives of this investigation were selected as the basis for assessments of the validity of specific features of state and federal clinical laboratory regulatory programs reflected in laboratory characteristics defining study groups. The conclusions set forth below represent those assessments and additional discoveries flowing from the investigation. Conclusion 1. In California, the requirement that the director have an earned doctorate does not appear to be ither a necessary or a sufficient condition to assure laborary quality. This conclusion is based upon the comparisons tween (a) hospital and non-doctoral-directed laboratories, which no pattern of statistically significant differences tween the two groups was found, and (b) One reason this finding is not conclusive is that the tatistically significantly lower proportion of overall errors chemical tests done by hospital laboratories may mean t, for some chemistry analytes that were not included in e study, the hospital laboratories were more accurate than e non-doctoral-directed laboratories. This finding may be other manifestation of the effect of scope of services on uality-the hospital laboratories in the study may perform rtain uncommon tests more often than the relatively mall non-doctoral-directed independent laboratories in the tudy. If so, more frequent performance ofthe tests could be expected to produce increased skill, or maintenance of higher levels of skills, in those laboratories "specializing" in the uncommon procedures.
Another possible interpretation of these findings is that there may be a cumulative difference in the proportion of errors in chemical tests that is not visible when the laboratories are compared analyte-by-analyte, because the data base involving no more than eight specimens per year per analyte may be too small to provide sufficient power to discriminate between comparison groups. Further research would be needed to assess these interpretations.
However, findings of the current study do not show any consistent pattern of superior performance by either the hospital or non-doctoral-directed independent laboratories that we intercompared.
Conclusion 2. There is substantial, although incomplete, evidence that regulation promotes laboratory quality in California. This conclusion is based upon two sets of comparisons. The first set of comparisons was between regulated non-doctoral-directed laboratories and unregulated laboratories in physicans ' Regulatory significance of conclusion 2. The findings leading to this conclusion strongly call into question the policy of granting exemptions from state and federal (Medicare) regulatory requirements to physicians' office laboraLories. These findings are reinforced by the findings of Part I, which showed that (a) there is a consistent national pattern ofhigher inter-laboratory coefficients ofvariation in proficiency test scores produced by unlicensed laboratories when compared with licensed-laboratory inter-laboratory coefficients of variation, and (b) full-service non-doctoraldirected laboratories consistently demonstrate statistically significantly higher performance than that of limited service U-POLs when compared with respect to five chemistry and five hematology analytes they perform in common.
The primary purpose of the federal regulatory systems covering clinical laboratories is to assure the quality of performance ofthe regulated laboratories. Additional research involving laboratories at all ranges of scope-of-services levels is needed to establish the general applicability of these findings. Such additional research should also include analysis of the potential relationship between scope of services and volume of work performed, to assess the independent effect that volume ofwork may have on laboratory quality.
Conclusion 3. The linear regression analysis of continuous data results demonstrated that, as measured by proficiency testing, there is strong evidence that laboratory performance is determined in part by the scope ofservices offered by a laboratory (16) . This finding is strongest in the unregulated laboratory study group. There is some association between scope of services and levels of performance in the licensed study groups, both as identified by Spearman rank sum correlations and by other descriptive evidence. However, these associations are not as strong or consistent as in the case of the unlicensed laboratories. These findings suggest that laboratories that come under federal or state regulatory standards (or professional standards accepted in lieu of governmental standards) demonstrate better performance at low scope-of-services levels in part as a result of being required to conform to regulatory requirements.
The evidence that scope-of-services levels partly determine laboratory outcome is strengthened by comparing results from the analysis using the original Part I methodology and the linear regression results reported here. There were stronger patterns of superior performance by regulated as compared with unregulated laboratories when scope of services was not considered in the analysis.
The scope-of-services variable may also be related to exemption from regulation for POLS. One of the primary reasons for exempting physicians' office laboratories from regulation is the low perceived threat to public health of low-volume laboratories (1 7). However, the volume of test-ing done in laboratories has been shown to be positively related to quality ofperformance (18) (19) (20) (21) (22) , and Crawley and colleagues (23) have linked larger size with higher performance. These findings raise the possibility that low laboratory volume may be related to low levels ofscope ofservices. if so, low volume and low scope-of-services levels may be cause for increased public-health concern in contrast to the presumed low public health impact from POLs.
Conclusion 4. The variables included in the analysis do not account for a considerable amount of the variance demonstrated in the data. There are at least two important considerations associated with this conclusion. First, although the scope of services is strongly associated with laboratory quality in many comparisons and the association is visible but not statistically discernible in many other comparisons, the scope variable does not account for a substantial amount of variance as measured by the R2 computation.
Second, although there were clear and often strong associations between director qualifications and laboratory performance in the comparison between the non-doctoral-directed laboratories and POLS, the director characteristic did not account for a significant amount of variance. This is additional evidence to support arguments that the function of a laboratory director may not be crucial in the determination of laboratory accuracy. The director's function may be predominantly management while quality control may be centered in (e.g.) the skill and training ofthe bench supervisore or other bench personnel (24) . Additional research is needed to identify other key independent co-variables affecting laboratory performance. Among those suggested in this report are volume of services and training/skill levels of supervisory personnel. 3. The operational features of the two programs were identical. AAB operated the ASIM service under contract. 4. For a detailed description of the methods used in comparing the proportions of errors for clustered data, see the report of Part I in reference 2 above. 5. California law exempts laboratories in solo-practitioner and group-practice offices from licensure (and therefore from meeting all state regulatory requirements for clinical laboratories except proficiency testing) if(1) they are exclusively owned and operated by the solo practitioner or members of the group practice; (2) they accept no specimens for analysis from outside the practice; and (3) if all physicians in the group practice share equally in the laboratory direction (California Business and Professions Code, 1978, Division 2, Chapter 3). The state inspects laboratories to assure that all physicians in the practice share equally in direction of the laboratory. When the state determines that one or more physicians in the practice specialize(s) in the director role, the laboratory is required to obtain a license. 6. Medicare exempts laboratories in physicians' offices and grOUp practices if they accept no more than 99 specimens per year per specialty (microbiology and serology, clinical chemistry, imniunohematology, hematology, pathology, and radiobioassay) from patients outside the practice (Medicare regulation 405.1310(a)). 7. The laboratories differ from U-POLs in at least two dimensions. The Medicare-exempt laboratories are in practices with a substantinily higher mean number of physicians than the unlicensed UPOLs. Also, it is probable that the Medicare-exempt laboratories produce a higher volume of work. It is not possible to verif' this assumption because accurate records of volume are not available. Both the size of the practice (as measured by the number of physicians who own it) and volume ofwork may be covariables with independent effects on the quality of performance in the laboratories. 8. One cautionary note is in order. Most hospital laboratories in California subscribe to the proficiency-testing service ofthe College of American Pathologists. The hospital laboratories in this study that subscribe to the AAB or ASIM proficiency testing service may not be representative of all hospital laboratories. For example, a review of the names and locations of the hospital laboratories selected indicates that smaller, rural hospitals may be over-represented in this sample. 9. A description offull-service subscription codes is given in reference 2 above. They consist ofSeries 15 or the equivalent in program modules of the AAB and ASIM proficiency testing services as offered in 1983. 10. California law requires that all laboratories, whether licensed or not, be proficiency tested on all laboratory procedures they perform in the laboratories. The scope of services reported to the proficiency-testing services is assumed to reflect the actual scope of services offered by laboratories in this investigation. 11. Professor Richard Brand (Department ofBiostatistics, School of Public Health, University of California, Berkeley) suggested the natural logarithm transformation of mean IzI and the specific form of linear regression analysis employed. 12. The Statistical Analysis System (SAS) program used is called PROC REG and may be found in the SAS User's Guide-Statistics, 1982 edition, pp 39-83.
